- Home
- ORRF vs FDMT Comparison
ORRF vs FDMT Comparison
Compare ORRF & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORRF | FDMT |
|---|---|---|
| Founded | 1919 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 791.0M | 695.3M |
| IPO Year | 1995 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ORRF | FDMT |
|---|---|---|
| Price | $42.60 | $13.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $42.00 | $31.71 |
| AVG Volume (30 Days) | 68.9K | ★ 1.0M |
| Earning Date | 04-21-2026 | 05-08-2026 |
| Dividend Yield | ★ 3.29% | N/A |
| EPS Growth | ★ 182.43 | 18.79 |
| EPS | ★ 2.21 | N/A |
| Revenue | $37,144,000.00 | ★ $85,209,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.15 | $70.28 |
| P/E Ratio | $19.16 | ★ N/A |
| Revenue Growth | 36.00 | ★ 230194.60 |
| 52 Week Low | $31.88 | $6.47 |
| 52 Week High | $43.81 | $16.93 |
Technical Indicators
Market Signals| Indicator | ORRF | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 52.22 | 50.23 |
| Support Level | $40.97 | $13.67 |
| Resistance Level | $42.48 | $14.00 |
| Average True Range (ATR) | 0.79 | 0.84 |
| MACD | 0.00 | -0.31 |
| Stochastic Oscillator | 62.55 | 24.12 |
Price Performance
Historical ComparisonAbout ORRF Orrstown Financial Services Inc
Orrstown Financial Services Inc is a financial holding company. Through its subsidiaries, it operates in the community banking segment and engages in lending activities, including commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending and deposit services, including checking, savings, time, and money market deposits. The Group also provides fiduciary, investment advisory, insurance, and brokerage services. It offers services to individuals, professionals, small businesses, and other enterprises across different locations in the United States through its branch network and client service centers.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).